{
    "nctId": "NCT06497322",
    "briefTitle": "Exercise Intervention in Women Diagnosed With Triple-negative Breast Cancer Receiving Oncologic Treatment",
    "officialTitle": "Effectiveness of High-intensity Interval Training During Neoadjuvant Immunochemotherapy on Complete Remission in Patients With Triple-negative Breast Cancer",
    "overallStatus": "NOT_YET_RECRUITING",
    "conditions": "Breast Cancer, Triple Negative Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 60,
    "primaryOutcomeMeasure": "Pathological complete remission of the tumor (pCR);",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Primary diagnosis of histologically verified triple-negative breast cancer (TNBC) measurable by ultrasound imaging\n* Stage of disease: T1c and nodal status N1-2 or Stage T2-4 and nodal status N0-2\n* Deemed eligible for intended treatment with Paclitaxel 80mg/m2 q1w x12, Carboplatin 1,5 AUC q1w x12, Pembrolizumab 200mg q3w x4 followed by Epirubicin 90mg/ m2 q3w x 4, Cyclophosphamid 600mg m2 q3w x 4, Pembrolizumab 200mg q3w x 4; by the treating physician\n* Treatment in curative intent with life expectancy \u2265 3 months\n* Female participants of childbearing potential must be willing to use an adequate method of contraception for the course of the study through 12 months after the last dose of study treatment for participants who have received cyclophosphamide, and 6 months after the last dose of study treatment for participants who did not.\n* Sufficient German language skills;\n\nExclusion Criteria:\n\n* History of invasive malignancy \u22642 years prior to signing informed consent except for adequately treated basal cell or squamous cell skin cancer or in situ cervical cancer.\n* Any history of previous systemic treatment for TNBC;\n* Any diseases that do not allow sports activity, such as:\n\n  * Clinically-manifest heart failure (NYHA III-IV);\n  * Respiratory partial or global insufficiency;\n  * Permanent thrombocytopenia \\<10,000/\u00b5l, e.g., refractory autoimmune thrombocytopenia;\n  * Congenital or acquired thrombocytopathies or coagulation disorders.\n  * Symptomatic CHD (clearance certificate required, stress ECG and cardiac ultrasound recommended if necessary);\n* Participation in another exercise study;",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}